Skip to content

Osteopathy for cervicogenic headache- OZKS_I

Osteopathy for cervicogenic headache- OZKS_I - OZKS_I

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00028109
Enrollment
400
Registered
2022-02-22
Start date
2016-05-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IHS Classification ICHD-3

Interventions

Group 1: Three osteopathic manipulative treatments were performed in a period of 4 weeks followed by a therapy-free interval of three to five months for follow-up. Group 2: Three standardized, sham tr

Sponsors

Universität Leipzig, Abt. Biomechanik
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: - age 18-55 years - unilateral or bilateral headache conforming to ICHD-II for more than 3 months. - Neck Disability Index (NDI score) above 15% - limited flexion-rotation test (FRT) of = 32° to one side.

Exclusion criteria

Exclusion criteria: - congenital developmental disorders - existing rheumatic diseases and tumour diseases - condition following surgery in the cervical, head and jaw region - cortisone or anticoagulant medication - existing arterial hypertension - chronic pain condition - pregnancy - cervical instability - radiculopathy/myelopathy

Design outcomes

Primary

MeasureTime frame
To investigate whether OMT versus placebo achieves significant and clinically relevant improvements (MCID) in Neck Disability Index (NDI) in patients with CGH. Measured at baseline T0, before first treatment T1, T2, T3, and at follow-up T4 after the three-month treatment-free interval.

Secondary

MeasureTime frame
To investigate whether OMT achieves significant and clinically relevant improvement in range of motion in the C1-2 motion segment compared to placebo in patients with CGH. Range of motion was assessed with the flexion-rotation test, measured by CROM (Cervical Range of Motion) in degrees. Examined at baseline T0, before first treatment T1, immediately after T2, before T3, and at follow-up T4 after the three-month treatment-free interval.

Countries

Austria, Germany, Switzerland

Contacts

Public ContactStephan Klemm

Institut für Osteopathie Oberharz

stephan_theodor.klemm@uni-leipzig.de+49151 11598931

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026